ILBEIGI, KAYHAN
ILBEIGI, KAYHAN
Dipartimento di Scienze della Vita
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
2026 Hendrickx, S.; Ilbeigi, K.; Thore, E. S. J.; Bertram, M. G.; Calvo-Alvarez, E.; Cintesun, S.; Olias-Molero, A. I.; Corral, M. J.; Mateo-Barrientos, M.; Estaquier, J.; Pomel, S.; Alunda, J. M.; Gul, S.; Van Bocxlaer, K.; Frezard, F.; Tavares, J.; Da Silva, A. C.; Costi, M. P.; Maes, L.; Caljon, G.
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
2026 Hendrickx, S.; Ilbeigi, K.; Thore, E. S. J.; Bertram, M. G.; Calvo-Alvarez, E.; Cintesun, S.; Olias-Molero, A. I.; Corral, M. J.; Mateo-Barrientos, M.; Estaquier, J.; Pomel, S.; Alunda, J. M.; Gul, S.; Van Bocxlaer, K.; Frezard, F.; Tavares, J.; Cordeiro Da Silva, A.; Costi, M. P.; Maes, L.; Caljon, G.
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
2026 Hendrickx, S.; Ilbeigi, K.; Thore, E. S. J.; Bertram, M. G.; Calvo-Alvarez, E.; Cintesun, S.; Olias-Molero, A. I.; Corral, M. J.; Mateo-Barrientos, M.; Estaquier, J.; Pomel, S.; Alunda, J. M.; Gul, S.; Van Bocxlaer, K.; Frezard, F.; Tavares, J.; Cordeiro Da Silva, A.; Costi, M. P.; Maes, L.; Caljon, G.
Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection
2024 Ilbeigi, K.; Barata, C.; Barbosa, J.; Bertram, M. G.; Caljon, G.; Costi, M. P.; Kroll, A.; Margiotta-Casaluci, L.; Thoré, E. S. J.; Bundschuh, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage | 1-gen-2026 | Hendrickx, S.; Ilbeigi, K.; Thore, E. S. J.; Bertram, M. G.; Calvo-Alvarez, E.; Cintesun, S.; Olias-Molero, A. I.; Corral, M. J.; Mateo-Barrientos, M.; Estaquier, J.; Pomel, S.; Alunda, J. M.; Gul, S.; Van Bocxlaer, K.; Frezard, F.; Tavares, J.; Da Silva, A. C.; Costi, M. P.; Maes, L.; Caljon, G. | |
| A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit | 1-gen-2026 | Hendrickx, S.; Ilbeigi, K.; Thore, E. S. J.; Bertram, M. G.; Calvo-Alvarez, E.; Cintesun, S.; Olias-Molero, A. I.; Corral, M. J.; Mateo-Barrientos, M.; Estaquier, J.; Pomel, S.; Alunda, J. M.; Gul, S.; Van Bocxlaer, K.; Frezard, F.; Tavares, J.; Cordeiro Da Silva, A.; Costi, M. P.; Maes, L.; Caljon, G. | |
| A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate | 1-gen-2026 | Hendrickx, S.; Ilbeigi, K.; Thore, E. S. J.; Bertram, M. G.; Calvo-Alvarez, E.; Cintesun, S.; Olias-Molero, A. I.; Corral, M. J.; Mateo-Barrientos, M.; Estaquier, J.; Pomel, S.; Alunda, J. M.; Gul, S.; Van Bocxlaer, K.; Frezard, F.; Tavares, J.; Cordeiro Da Silva, A.; Costi, M. P.; Maes, L.; Caljon, G. | |
| Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection | 1-gen-2024 | Ilbeigi, K.; Barata, C.; Barbosa, J.; Bertram, M. G.; Caljon, G.; Costi, M. P.; Kroll, A.; Margiotta-Casaluci, L.; Thoré, E. S. J.; Bundschuh, M. |